adamantane has been researched along with Respiratory Insufficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brenner, SR | 1 |
| Rekalova, EM | 1 |
2 other study(ies) available for adamantane and Respiratory Insufficiency
| Article | Year |
|---|---|
The potential of memantine and related adamantanes such as amantadine, to reduce the neurotoxic effects of COVID-19, including ARDS and to reduce viral replication through lysosomal effects.
Topics: Adamantane; Amantadine; COVID-19; Humans; Lysosomes; Memantine; Respiratory Distress Syndrome; Respiratory Insufficiency; SARS-CoV-2; Virus Replication | 2020 |
[The immunomodulator kemantan in the treatment of patients with exacerbated chronic obstructive bronchitis].
Topics: Adamantane; Adult; Bronchitis; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Immunity, Cellular; Male; Respiratory Insufficiency | 1992 |